Internal Medicine, Interventional Cardiology · Beaumont, TX
NPI
1609871334
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
740 Hospital Dr, Suite 260
Beaumont, TX, 77701
Phone (409) 835-4003
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
2,067 services
Medicare patients, 2024
714
Average age 75
Drug cost, 2024
$1.3M
8,401 prescriptions
Company payments, 2025
$1,175
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wayne S Margolis was code 99214 (office e&m - established), 534 times for 267 patients. In total Wayne S Margolis billed 2,067 services in 38 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 534 | 267 | $79.95 | $43K |
| 93000 Electrocardiogram | Office | 485 | 270 | $9.16 | $4,443 |
| 93010 Electrocardiogram | Facility | 413 | 376 | $5.99 | $2,473 |
| 93306 Echocardiography (TTE/TEE) | Facility | 156 | 150 | $50.75 | $7,918 |
| 99215 Office E&M - Established | Office | 131 | 89 | $129.81 | $17K |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 61 | 61 | $27.51 | $1,678 |
| 93227 Electrocardiogram | Facility | 37 | 34 | $11.40 | $422 |
| 93922 Duplex Scan - Extremity Arteries | Facility | 36 | 33 | $7.65 | $275 |
| 93227 Electrocardiogram | Office | 28 | 28 | $12.75 | $357 |
| 78452 Myocardial Perfusion Scan | Facility | 24 | 24 | $56.57 | $1,358 |
| 93925 Duplex Scan - Extremity Arteries | Facility | 17 | 17 | $26.36 | $448 |
| 93978 Duplex Scan - Extremity Arteries | Facility | 13 | 13 | $26.20 | $341 |
| 94618 Pulmonary Function Testing | Office | 13 | 13 | $18.59 | $242 |
By year: 2022 $98K for 2,128 services; 2023 $88K for 2,200 services; 2024 $85K for 2,067 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wayne S Margolis prescribed most often to Medicare patients was Amlodipine Besylate, with 783 prescriptions and refills. In total Wayne S Margolis wrote 8,401 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 783 | 2,147 | 217 | $5,222 |
| Atorvastatin Calcium Generic | 704 | 1,930 | 202 | $7,607 |
| Ezetimibe Generic | 681 | 1,899 | 208 | $16K |
| Rosuvastatin Calcium Generic | 676 | 1,954 | 201 | $12K |
| Eliquis Apixaban | 393 | 743 | 96 | $414K |
| Clopidogrel Clopidogrel Bisulfate | 376 | 1,099 | 112 | $4,506 |
| Metoprolol Succinate Generic | 305 | 854 | 82 | $4,660 |
| Irbesartan Generic | 292 | 810 | 81 | $4,567 |
| Chlorthalidone Generic | 286 | 763 | 78 | $3,961 |
| Carvedilol Generic | 247 | 688 | 69 | $2,841 |
| Lisinopril Generic | 202 | 562 | 59 | $1,732 |
| Hydrochlorothiazide Generic | 152 | 431 | 50 | $1,185 |
| Ramipril Generic | 138 | 384 | 34 | $2,566 |
| Jardiance Empagliflozin | 137 | 235 | 34 | $133K |
| Bisoprolol Fumarate Generic | 135 | 396 | 43 | $3,355 |
Brand drugs: - claims; generic drugs: 7,190 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wayne S Margolis $1,175 ($1,175 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $305.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $305 |
| Merck Sharp & Dohme LLC MRK | 7 | $157 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $102 |
| Abbott Laboratories ABT | 1 | $98.01 |
| Boston Scientific Corporation BSX | 4 | $86.91 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $76.17 |
| Kestra Medical Technology Services, Inc. | 2 | $66.63 |
| Cleerly, Inc. | 3 | $63.09 |
| Amgen Inc. AMGN | 3 | $44.62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.